以产业创新场景赋能“立园满园” 成都未来医学城获评“中国特色生物医药园区优秀案例”

Core Insights - The 42nd National Pharmaceutical Industry Information Annual Conference and the 2025 Beijing-Changping Life Science Forum highlighted the Chengdu Future Medical City as a "model for future medical innovation and transformation" due to its integrated innovation and transformation system in the "medical education research production" sector [1][2] Group 1: Recognition and Achievements - Chengdu Future Medical City was recognized alongside eight other renowned industrial parks from major cities like Beijing, Shanghai, and Shenzhen, marking a significant achievement in national-level recognition for its contributions to technological innovation and results transformation [1] - The park's innovative practices address critical pain points in the biopharmaceutical industry, particularly the disconnect between clinical demand and supply-side capabilities, providing a valuable "Chengdu sample" and "Sichuan experience" for national biopharmaceutical park transformation [1] Group 2: Innovation and Collaboration - During the event, Chengdu Future Medical City launched 14 innovative scenarios across five areas, focusing on the application of new technologies and products, market feedback, user experience, new business models, and pricing mechanisms [2] - The initiative aims to create a diverse testing environment for industrial development, technological innovation, and resource linkage, ultimately facilitating cooperation and market expansion for both local and external enterprises [2] - The city plans to leverage this event as a starting point to deepen clinical demand-oriented translational medical research, accelerate the cultivation of future industries, and enhance the integration of innovation, industry, finance, and talent [2]